Atlas Trials

Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment

Clinical trial NCT01527929 · COMPLETED

Trial details

NCT number
NCT01527929
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasm Malignant
Start date
2012-04-01
Primary completion
2013-11-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.